JNK inhibitor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S275000, C514S340000, C514S342000, C544S331000, C544S333000, C546S270400, C546S271400

Reexamination Certificate

active

10470751

ABSTRACT:
The present invention relates to a c-Jun N-terminal kinase inhibitor containing an azole compound (I) substituted by a nitrogen-containing aromatic group having substituent(s)(except a compound represented by the formula:) or a salt thereof or a prodrug thereof.

REFERENCES:
patent: 4612321 (1986-09-01), Terao et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5792778 (1998-08-01), de Laszlo et al.
patent: 6083949 (2000-07-01), Liverton et al.
patent: 6436966 (2002-08-01), Ohkawa et al.
patent: 6962933 (2005-11-01), Ohkawa et al.
patent: 2002/0032183 (2002-03-01), LoGrasso et al.
patent: 2004/0053973 (2004-03-01), Ohkawa et al.
patent: 0 149 884 (1984-07-01), None
patent: 1070711 (2001-01-01), None
patent: 1180518 (2002-02-01), None
patent: 2000-302680 (2000-10-01), None
patent: WO 97/05877 (1997-02-01), None
patent: WO 97/35856 (1997-10-01), None
patent: WO 97/47618 (1997-12-01), None
patent: WO 98/52940 (1998-11-01), None
patent: WO 98/56788 (1998-12-01), None
patent: WO 99/18942 (1999-04-01), None
patent: WO 99/21555 (1999-05-01), None
patent: WO 99/32121 (1999-07-01), None
patent: WO 99/64418 (1999-12-01), None
patent: WO-00/26209 (2000-05-01), None
patent: WO 00/31063 (2000-06-01), None
patent: WO 00/63204 (2000-10-01), None
patent: WO 00/64894 (2000-11-01), None
patent: WO 01/10865 (2001-02-01), None
patent: WO 01/12621 (2001-02-01), None
patent: WO 01/30778 (2001-05-01), None
patent: WO 01/57022 (2001-08-01), None
patent: WO 01/74811 (2001-10-01), None
patent: WO 02/10137 (2002-02-01), None
Lisnock et al., Biochemistry, 37, 16573-16581, 1998.
Bagowski et al., Current Biology, 11, 1176-1182, 2001.
Davis, Cell, 103, 239-252, Oct. 13, 2000.
Omura et al., J. Mol. Cell Cardiol., 31, 1269-1279, 1999.
Yue et al., Circulation Research, 82, 166-174, 1998.
Liverton, et al. “Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase” J. Med. Chem. 42:2180-2190 (1999).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

JNK inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with JNK inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and JNK inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3741136

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.